97 related articles for article (PubMed ID: 30969)
21. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
22. [Experience with the use of a beta-blocking agent in the community treatment of arterial hypertension].
Bucci A; Catalucci AM; Giampaoli S
Clin Ter; 1981 Jun; 97(5):521-7. PubMed ID: 6115733
[No Abstract] [Full Text] [Related]
23. [Effects of new beta receptor blocking agent Acebutolol in patients with essential, renal, and broderline hypertension].
Werning C
Med Welt; 1977 Sep; 28(39):1564-6. PubMed ID: 22016
[No Abstract] [Full Text] [Related]
24. Isradipine in monotherapy and in combination with bopindolol: results of a 3-month multicentre study in hypertensives.
Dzúrik R; Fetkovská N; Dvorák I; Jonás P; Markuljak I; Petr P; Kotlík I; Widimský J
Cor Vasa; 1990; 32(2 Suppl 1):42-53. PubMed ID: 1974488
[TBL] [Abstract][Full Text] [Related]
25. [Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
Sznajderman M; Cybulska I; Niegowska J; Zawadzki Z; Sznajderman M
Kardiol Pol; 1985; 28(7):489-99. PubMed ID: 2868145
[No Abstract] [Full Text] [Related]
26. [The effect of beta blockers on the QT interval: the possible role of mechanisms other than beta block].
Pala AM; Ricciardelli D; Sanna A; Vinattieri MA
Minerva Med; 1989 Dec; 80(12):1283-7. PubMed ID: 2576115
[TBL] [Abstract][Full Text] [Related]
27. [Frequently used beta-blockers and circulating thyroid hormones].
Custro N; Scafidi V; De Francisci MC
Minerva Endocrinol; 1986; 11(3):185-9. PubMed ID: 2879217
[No Abstract] [Full Text] [Related]
28. Comparative review of beta-blocking agents.
Jackson EA; Sullman SA
Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
[No Abstract] [Full Text] [Related]
29. Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists.
Dubois D; Petitcolas J; Temperville B; Klepper A; Catherine P
Br J Clin Pharmacol; 1982; 13(Suppl 2):375S-378S. PubMed ID: 6125190
[No Abstract] [Full Text] [Related]
30. [Pharmacokinetics of beta-blockers in arterial hypertension. Practical value].
Safar M; Weiss Y; Chau NP; Kheder A; Levenson J; Milliez P
Nouv Presse Med; 1978 Sep; 7(31):2759-60. PubMed ID: 30957
[No Abstract] [Full Text] [Related]
31. [Therapy of hypertension using various beta receptor blockaders (timolol, alprenolol, prindolol].
Heinze A; Wessels F; Losse H
Verh Dtsch Ges Kreislaufforsch; 1975; 41():380-2. PubMed ID: 7887
[No Abstract] [Full Text] [Related]
32. [The influence of 0.85% RS-timolol and 0.5% S-timolol on intraocular pressure and systemic arterial blood pressure, heart rate, ECG, expiratory capacity in patients with ocular hypertension and primary open-angle glaucoma].
Czechowicz-Janicka K; Staszkiewicz J; Strzałkowska M; Krajewska M; Popiołek B; Christman A
Klin Oczna; 1999; 101(5):333-7. PubMed ID: 10714069
[TBL] [Abstract][Full Text] [Related]
33. Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Part 2.
Kanno M; Araie M; Masuda K; Takase M; Kitazawa Y; Shiose Y; Azuma I; Ogawa N; Ohdo S
Arzneimittelforschung; 2006; 56(12):820-5. PubMed ID: 17260669
[No Abstract] [Full Text] [Related]
34. Position of beta blockers in antihypertensive therapy.
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S1-87. PubMed ID: 2439810
[No Abstract] [Full Text] [Related]
35. Variability in the preventive action of the B-blockers on genetic hypertension in the rat.
de Clavière M; Heyndrickx JP; Brotelle R; Colot M
Paroi Arterielle; 1980; 6(4):227-31. PubMed ID: 6120497
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular effects of befunolol, betaxolol and timolol eye drops.
Dorigo MT; Cerin O; Fracasso G; Altafini R
Int J Clin Pharmacol Res; 1990; 10(3):163-6. PubMed ID: 1977708
[TBL] [Abstract][Full Text] [Related]
37. [Acebutolol in the treatment of arterial hypertension. Clinical study].
Lucsko M; Chaignon M; Guédon J
Nouv Presse Med; 1975 Dec; 4(46 Suppl):3287-9. PubMed ID: 768911
[TBL] [Abstract][Full Text] [Related]
38. Beta receptor blockers on ergometric work in hypertensive patients.
Franz IW; Lohmann FW; Rocker I; Kothari P
Indian Heart J; 1979; 31(5):259-62. PubMed ID: 42612
[No Abstract] [Full Text] [Related]
39. [Clinical effect of beta-adrenergic blockers in the treatment of hypertension with regard to a decrease in peripheral resistance].
Trifunović S
Lijec Vjesn; 1984; 106(11-12):526-30. PubMed ID: 6151619
[No Abstract] [Full Text] [Related]
40. [The comparison of clinical effectiveness of perindopril and acebutolol in the primary hypertension treatment].
Pieniazek W; Franczuk P; Janicki K
Przegl Lek; 2001; 58(5):411-4. PubMed ID: 11603173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
